Skip to main content
INVITES BIOCORE CO., LTD logo

INVITES BIOCORE CO., LTD — Investor Relations & Filings

Ticker · 216400 ISIN · KR7216400002 KO Professional, scientific and technical activities
Open in API
Filings indexed 169 across all filing types
Latest filing 2018-12-11 Regulatory Filings
Country KR South Korea
Listing KO 216400

About INVITES BIOCORE CO., LTD

https://www.bio-core.com/eng/main/main.…

INVITES BIOCORE CO., LTD. is a Contract Research Organization (CRO) that provides comprehensive services to support new drug development. Established in 2001, the company partners with pharmaceutical firms, research institutes, and medical institutions. Its primary services include bioanalytical testing, central lab services, and clinical trial support. The company also specializes in genomic analysis, offering genetic and cell screening, individual genome analysis, and related services to facilitate the advancement of precision medicine and personalized healthcare.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal notice of a corporate action. Given it is a regulatory announcement that does not fit into specific categories like dividend or share buyback, it falls under the general regulatory filing category.
2018-12-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) where directors or major shareholders report their personal share transactions (insider trading). This matches the definition of 'Director's Dealing' (DIRS).
2018-11-30 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) event held by BioCore. It lists the date, location, attendees, and agenda of the meeting. Since it is a brief notification summarizing the occurrence of an event rather than the full presentation deck or a comprehensive financial report, it falls under the category of a regulatory announcement regarding corporate activities.
2018-11-28 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves or a full report, and it fits the criteria for a regulatory notification of an event, it is classified as a Regulatory Filing (RNS).
2018-11-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.